Boliang Lou is the CEO of Pharmaron. Lou is based in China. Lou was educated at Shanghai Institute of Organic Chemistry.
Latest on The Wire
See all →Manufacturing roundup: Pharmaron secures acquisition of a Rhode Island facility; GSK to open hub in South America
May 26 · via Endpoints NewsChina-based pharmaceutical company to acquire former Rhodes site
May 25 · via Providence Business NewsPharmaron Acquires Commercial API Manufacturing Facility in the United States
May 24 · via Business WireLou Boliang
Apr 5 · via Forbes
Recent developments
AI summary of recent coverageRecent coverage has focused on Pharmaron's aggressive expansion through a series of facility acquisitions across multiple geographies, including a Rhode Island manufacturing plant, a UK site acquired from Recipharm, and a bioprocessing facility. The coverage reflects the company's strategy to grow its contract research and manufacturing operations in the United States and Europe while reporting improved profitability amid this international expansion.
Summarized from the headlines below; see each source for the full story.
Key Facts
Source: Wikidata ↗- Citizenship
- United States
- Education
- Shanghai Institute of Organic Chemistry
Our coverage
On CEOInsider
No feature yet. When we publish a feature, interview or cover story on Boliang Lou, it will appear here — and tie into the news timeline.
10 stories tracked
In the News
- Endpoints News·
Manufacturing roundup: Pharmaron secures acquisition of a Rhode Island facility; GSK to open hub in South America
- Providence Business News·
China-based pharmaceutical company to acquire former Rhodes site
- Business Wire·
Pharmaron Acquires Commercial API Manufacturing Facility in the United States
- Forbes·
Lou Boliang
- cleanroomtechnology.com·
Pharmaron Beijing acquires UK site from Recipharm
- Forbes·
Pharmaron Beijing Says Profit Rose Amid U.S., UK Expansion
- fiercepharma.com·
Recipharm unloads a pair of plants in separate deals as part of its streamlining, growth strategy
- Genetic Engineering and Biotechnology News·
Pharmaron Acquires Bioprocessing Site from AbbVie
- Fierce Biotech·
Chinese CRMO Pharmaron snaps up U.S. contract research company Absorption Systems
- Fierce Biotech·
Chinese CRO Pharmaron leases Merck facility in the U.K.
Boliang Lou: FAQ
- What company does Boliang Lou lead?
- Boliang Lou is CEO of Pharmaron.
- Where was Boliang Lou educated?
- Boliang Lou studied at Shanghai Institute of Organic Chemistry.